Peptide therapy TikTok claims: what the science actually supports

What did @eliane.liah2 actually say?

Almost nothing, technically. The entire transcript of this 70,800-view video is: "Thanks for watching, and I'll see you in the next video!" That is a sign-off, not a claim. There is no substantive health information to evaluate from the transcript alone.

This is worth flagging because it creates a real problem for fact-checking. The video sits in a category tagged to peptides like BPC-157, TB-500, CJC-1295, ipamorelin, GHK-Cu, MK-677, semax, selank, and related compounds. These are not low-stakes wellness supplements. Several of them are research chemicals with no FDA approval for human use. When a video reaches nearly 71,000 views and the only captured text is a goodbye line, either the transcript is incomplete or the content was entirely visual and on-screen text, neither of which can be properly evaluated here.

We will treat this fact-check as a primer on what viewers in this content category are commonly told, and what the actual evidence looks like.

Does the science back this up?

There is no specific claim in the transcript to test. But given the peptide category this video was filed under, it is worth being direct about where the science actually stands on these compounds, because the TikTok peptide space is full of overreach.

BPC-157 has shown regenerative effects in rodent studies, including tendon and gut repair, but zero completed human clinical trials as of 2024. That gap matters enormously. TB-500, a synthetic fragment of thymosin beta-4, has similar animal data and similar absence of human trial evidence. CJC-1295 and ipamorelin are growth hormone secretagogues with some human pharmacokinetic data, but no long-term safety studies. MK-677 is an oral ghrelin mimetic that raises IGF-1, with short-term trials in elderly populations showing modest effects on lean mass (Nass et al., 2008, Annals of Internal Medicine), but it also raises fasting glucose and prolactin. GHK-Cu has in vitro and animal wound-healing data. Semax and selank are Russian-developed nootropic peptides with very limited English-language trial data.

The honest summary: animal data is promising for several of these. Human evidence is thin to nonexistent for most of them.

What did they get wrong (or right)?

Because the transcript contains no factual claims, there is nothing to grade directly. That said, the silence is itself a data point. Content creators in this space frequently let on-screen visuals or voiceovers carry the substantive claims while the spoken transcript stays vague or promotional. This makes accountability harder and misinformation easier to spread without a clear record.

What the peptide content category consistently gets wrong on TikTok, whether or not this specific video does it, is the implied equivalence between animal study results and human outcomes. A peptide healing a rat's Achilles tendon in a controlled lab setting is not the same as it healing yours after a self-injection bought from a research chemical vendor. The dose, the purity, the delivery method, and the regulatory status are all completely different situations.

Creators who present peptides as accessible, low-risk optimization tools without mentioning that most have never passed phase II human trials are leaving out the most important part of the story.

What should you actually know?

If you watched this video hoping to learn something actionable about peptide therapy, here is what the evidence actually supports right now.

• No peptide in this category is FDA-approved for the indications most commonly promoted online, including injury recovery, anti-aging, or cognitive enhancement.
• Compounded versions of these peptides, often sold through telehealth platforms or gray-market research chemical sites, are not equivalent to pharmaceutical-grade compounds in terms of purity or dosing verification.
• The FDA issued a guidance in 2023 removing BPC-157 and TB-500 from the list of permissible compounded substances, citing safety concerns and lack of clinical evidence. That is a regulatory signal worth taking seriously.
• Growth hormone secretagogues like CJC-1295, ipamorelin, and MK-677 carry real risks including fluid retention, insulin resistance, and potential effects on cancer cell proliferation, a concern flagged because IGF-1 elevation has been associated with tumor growth in some studies (Pollak, 2012, Nature Reviews Cancer).
• If you are considering peptide therapy, the conversation belongs with a licensed clinician who can review your bloodwork, not a TikTok comment section.

The 70,000-plus views this video received suggest people are genuinely curious about peptides. That curiosity deserves better than a sign-off line and an assumption that viewers already know the risks.